- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.75 Å
- Oligo State
- monomer
- Ligands
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x KS8: fosinoprilat(Non-covalent)
- 5 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 3 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
- 2 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- 4 x ACT: ACETATE ION(Non-functional Binders)
- 4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x ZN: ZINC ION(Non-covalent)
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- 1 x CA: CALCIUM ION(Non-covalent)
- 1 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cozier, G.E. et al., Structural basis for the inhibition of human angiotensin-1 converting enzyme by fosinoprilat. Febs J. (2022)
- Release Date
- 2022-06-22
- Peptides
- Angiotensin-converting enzyme, soluble form: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A